The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Zymeworks BC Inc shares valued at $1,689,541 were purchased by EcoR1 Capital, LLC on Jan 16 ’25. At $13.88 per share, EcoR1 Capital, LLC acquired 121,681 shares. The insider’s holdings grew to 15,700,413 shares worth approximately $206.93 million following the completion of this transaction.
Also, EcoR1 Capital, LLC purchased 19,748 shares, netting a total of over 273,998 in proceeds. Following the buying of shares at $13.87 each, the insider now holds 15,720,161 shares.
Before that, EcoR1 Capital, LLC had added 74,125 shares to its account. In a trade valued at $992,875, the Director bought Zymeworks BC Inc shares for $13.39 each. Upon closing the transaction, the insider’s holdings increased to 74,125 shares, worth approximately $204.09 million.
As published in a research note from JP Morgan on December 16, 2024, Zymeworks BC Inc [ZYME] has been rated up from a Neutral to an Overweight and the price target has been revised to $18. Analysts at Leerink Partners upgraded the stock from ‘”a Market perform”‘ to ‘”an Outperform”‘ outlook in a report released in early November. As of November 01, 2024, Wells Fargo has decreased its “an Overweight” rating to a “an Equal weight” for ZYME.
Analyzing ZYME Stock Performance
During the last five days, there has been a drop of approximately -4.91%. Over the course of the year, Zymeworks BC Inc shares have dropped approximately -9.97%. Shares of the company reached a 52-week high of $17.07 on 01/03/25 and a 52-week low of $12.40 on 03/04/25. A 50-day SMA is recorded $14.20, while a 200-day SMA reached $12.25.
Support And Resistance Levels for Zymeworks BC Inc (ZYME)
According to the 24-hour chart, there is a support level at 12.86, which, if violated, would cause prices to drop to 12.54. In the upper region, resistance lies at 13.34. The next price resistance is at 13.50. RSI (Relative Strength Index) is 42.46 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.99, which suggests the price will decrease in the coming days. Percent R is at 72.63%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Which companies own the most shares of Zymeworks BC Inc (ZYME)?
On January 04, 2023, H.C. Wainwright assigned a price target of “a Neutral” to the stock and reiterated coverage with a $8.
